Our history started more than 35 years ago when a young entrepreneur, Dr Nicolas Stylianides, founded Aegis Pharmaceuticals Ltd (now Delorbis Pharmaceuticals Ltd). Dr Stylianides graduated from prestigious USA Universities obtaining a B.S. degree in Chemical Engineering (Columbia University) and a Ph.D. Degree in Organic Chemistry in the synthesis of biologically active substances - Drug Discovery (University of Pennsylvania) with numerous publications in prestigious journals. This Ivy League training swiftly enabled him to enter the field of pharmaceuticals. After training in well-established pharmaceutical company in Europe, he transferred pharmaceutical technology to Cyprus by establishing Aegis, the present day Delorbis, as founder and later as CEO. Dr Stylianides also held a university teaching position for Pharmaceutical Technology and Physical Chemistry. He later moved into the area of pharmaceutical consulting and founded Medelligent Pharmaceuticals Ltd. Dr Stylianides is a registered Qualified Person (QP) for human and veterinary medicinal and is currently the QP for several companies in Cyprus and the UK.

Dr. Golfo Skokotas holds a B.A. degree in Chemistry (Rutgers University) and a Ph.D. degree in Organic Chemistry in the synthesis of biologically active natural products and their analogues - Drug Discovery (University of Pennsylvania and University of California, San Diego) with numerous publications in prestigious journals, including one for a novel molecule that bears her name (Golfomycin). Dr. Skokotas holds patents related to her work. She was involved in the establishment of Aegis Pharmaceuticals Ltd (now Delorbis Pharmaceuticals Ltd) and has over 30 years of experience in Quality Management Systems (QMS), GMP/GDP principles, audits, regulatory procedures, and pharmacovigilance requirements. Dr Skokotas is a co-founder of Medelligent Pharmaceuticals Ltd. She is a registered Qualified Perso for human and vetinary medicanal products  and currently acts as Quality Manager, Regulatory Manager, Qualified Person (QP) and Local Qualified Person for Pharmacovigilance (LQPPV) for various companies.

Shafi Uddin is a pharmacist with over 15 years of experience in the pharmaceutical industry. He is a Senior GMP and Pharmaceutical Quality Systems (QMS) Consultant with expertise in establishing and optimizing QMS across global pharmaceutical markets. He has specialized knowledge in EU GMP, WHO GMP, and PIC/S regulatory framework with proven success in guiding manufacturing companies through the GMP certification processes. Shafi is also familiar with the GMP principles of herbal medicinal products including cannabis.  

He is currently active with Medelligent in Asia. His competencies include but not limited to QMS architecture, quality risk management, comprehensive validation programs (equipment, process, cleaning, utilities), GxP documentation, ALCOA+ compliance, supplier qualification etc. He combines hands-on implementation experience with strategic objective to deliver sustainable solutions.